Skip to main content

Advertisement

SpringerLink
Log in

Electrophysiologic evaluation of facial nerve functions after oxaliplatin treatment

  • Original Article
  • Published:
Cancer Chemotherapy and Pharmacology Aims and scope Submit manuscript

Abstract

Purpose

This study analyzes the effect of oxaliplatin treatment on the facial nerve. The facial nerve is the most commonly paralyzed cranial motor nerve because it advances through a long, curved bone canal. Electroneurography and blink reflex are the electrophysiological measurements used for evaluating facial nerve function. Oxaliplatin is a cytotoxic agent used in adjuvant or palliative systemic therapy for colorectal cancer treatment.

Methods

This study was performed on 20 individuals who were at least 18 years old at Hacettepe University Ear Nose Throat Department, Audiology and Speech Disorders Unit, and Neurology Division EMG Laboratory as they received oxaliplatin treatment from Hacettepe University Oncology Hospital. Electroneurography and blink-reflex values were recorded and examined. The parameters taken during the second and fourth months were compared for this purpose.

Results

This study shows that the prolongation of distal latencies of compound muscle action potential is statistically significant, the amplitudes showed no difference. The ENoG results were analyzed, the prolongation of latency measurements between pre-treatment and the fourth month after treatment were statistically significant. The blink-reflex results showed that comparison with the baseline values, the prolongation of latencies in R1 measurements between pre-treatment, the second month, and the fourth month were significant.

Conclusions

The facial nerve is affected asymptomatically by oxaliplatin treatment. During oxaliplatin treatment, the evaluation of facial nerve function could be beneficial for patients by improving their quality of life. Electroneurography and blink-reflex tests can be used in the early evaluations of different medicines to determine their neurotoxicity.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Quasthoff S, Hartung HP (2002) Chemotherapy-induced peripheral neuropathy. J Neurol 249(1):9–17

    Article  CAS  PubMed  Google Scholar 

  2. Custodio A, Moreno-Rubio J, Aparicio J, Gallego-Plazas J, Yaya R, Maurel J et al (2013) Pharmacogenetic predictors of severe peripheral neuropathy in colon cancer patients treated with oxaliplatin-based adjuvant chemotherapy: a GEMCAD group study. Ann Oncol 25(2):398–403

    Article  PubMed  Google Scholar 

  3. André T, Boni C, Mounedji-Boudiaf L, Navarro M, Tabernero J, Hickish T et al (2004) Oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment for colon cancer. N Engl J Med 350(23):2343–2351

    Article  PubMed  Google Scholar 

  4. Lièvre A, Samalin E, Mitry E, Assenat E, Boyer-Gestin C, Lepère C et al (2009) Bevacizumab plus FOLFIRI or FOLFOX in chemotherapy-refractory patients with metastatic colorectal cancer: a retrospective study. BMC Cancer. 9(1):347

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  5. Cersosimo RJ (2005) Oxaliplatin-associated neuropathy: a review. Ann Pharmacother 39(1):128–135

    Article  CAS  PubMed  Google Scholar 

  6. Esslen E. The acute facial palsies: investigations on the localization and pathogenesis of meato-labyrinthine facial palsies: Springer Science & Business Media; 2012

  7. VanSwearingen JM, Cohn JF, Bajaj-Luthra A (1999) Specific impairment of smiling increases the severity of depressive symptoms in patients with facial neuromuscular disorders. Aesthetic Plast Surg 23(6):416–423

    Article  CAS  PubMed  Google Scholar 

  8. Ardic FN, Ardic F, Topaloglu J, Öncel S, Uguz MZ, Topalogu D (1997) Electroneurography in the late period of Bell’s palsy. Acta Otolaryngol 117(3):325–328

    Article  CAS  PubMed  Google Scholar 

  9. Lee KJ (2015) KJ Lee’s essential otolaryngology, 11th edn. McGraw-Hill Education, New York

    Google Scholar 

  10. Ardic F, Ardic F, Topaloglu J, Öncel S, Uguz M, Topalogu D (1997) Electroneurography in the late period of Bell’s palsy. Acta Otolaryngol 117(3):325–328

    Article  CAS  PubMed  Google Scholar 

  11. Akkuzu B (2008) Fasiyal Sinir Hastalıklarında Muayene ve Tanı Teknikleri. Türkiye Klinikleri Kulak Burun Boğaz Özel Dergisi. 1(1):8

    Google Scholar 

  12. Hall JWI. Nonauditory clinical neurophysiology. In: D. DS (ed). New handbook of auditory evoked responses. USA: Pearson Education; 2007

  13. Cruccu G, Deuschl G (2000) The clinical use of brainstem reflexes and hand-muscle reflexes. Clin Neurophysiol 111(3):371–387

    Article  CAS  PubMed  Google Scholar 

  14. Gültekin M, Boztaş G (2014) Türkiye kanser istatistikleri. Türkiye Halk Sağlığı Kurumu, Sağlık Bakanlığı, p 43

    Google Scholar 

  15. Pasetto LM, D’Andrea MR, Rossi E, Monfardini S (2006) Oxaliplatin-related neurotoxicity: how and why? Crit Rev Oncol/Hematol 59(2):159–168

    Article  Google Scholar 

  16. Kannarkat G, Lasher EE, Schiff D (2007) Neurologic complications of chemotherapy agents. Curr Opin Neurol 20(6):719–725

    CAS  PubMed  Google Scholar 

  17. Griffith KA, Zhu S, Johantgen M, Kessler MD, Renn C, Beutler AS et al (2017) Oxaliplatin-induced peripheral neuropathy and identification of unique severity groups in colorectal cancer. J Pain Symptom Manag. 54(5):701-6. e1

    Article  Google Scholar 

  18. Pulvers JN, Marx G (2017) Factors associated with the development and severity of oxaliplatin-induced peripheral neuropathy: a systematic review. Asia-Pac J Clin Oncol 13(6):345–355

    Article  PubMed  Google Scholar 

  19. Akkuzu B (2008) Fasiyal Sinir Hastalıklarında Muayene ve Tanı Teknikleri. Turkiye Klinikleri J Ear Nose Throat-Spec Topics. 1(1):8–13

    Google Scholar 

  20. Adelsberger H, Quasthoff S, Grosskreutz J, Lepier A, Eckel F, Lersch C (2000) The chemotherapeutic oxaliplatin alters voltage-gated Na + channel kinetics on rat sensory neurons. Eur J Pharmacol 406(1):25–32

    Article  CAS  PubMed  Google Scholar 

  21. Baba M, Fowler CJ, Jacobs JM, Gilliatt RW (1982) Changes in peripheral nerve fibres distal to a constriction. J Neurol Sci 54(2):197–208

    Article  CAS  PubMed  Google Scholar 

  22. Logician EL, Kelly JJ, Adelman LS (1994) Nerve conduction and biopsy correlation in over 100 consecutive patients with suspected polyneuropathy. Muscle Nerve 17(9):1010–1020

    Article  Google Scholar 

  23. Feinberg DM, Preston DC, Shefner JM, Logigian EL (1999) Amplitude-dependent slowing of conduction in amyotrophic lateral sclerosis and polyneuropathy. Muscle Nerve 22(7):937–940

    Article  CAS  PubMed  Google Scholar 

  24. Lehky TJ, Leonard GD, Wilson RH, Grem JL, Floeter MK (2004) Oxaliplatin-induced neurotoxicity: acute hyperexcitability and chronic neuropathy. Muscle Nerve 29(3):387–392

    Article  CAS  PubMed  Google Scholar 

  25. Kazem SS, Behzad D (2006) Role of blink reflex in diagnosis of subclinical cranial neuropathy in diabetic mellitus type II. Am J Phys Med Rehabil 85(5):449–452

    Article  PubMed  Google Scholar 

  26. Casale R, Frazzitta G, Fundarò C, Balbi P, Rosso AD, Bertinotti L et al (2004) Blink reflex discloses CNS dysfunction in neurologically asymptomatic patients with systemic sclerosis. Clin Neurophysiol 115(8):1917–1920

    Article  PubMed  Google Scholar 

  27. Cruccu G, Iannetti GD, Marx JJ, Thoemke F, Truini A, Fitzek S et al (2005) Brainstem reflex circuits revisited. Brain 128(2):386–394

    Article  CAS  PubMed  Google Scholar 

  28. Kimura J (1981) Conduction abnormalities of the facial and trigeminal nerves in polyneuropathy. Muscle Nerve 5(9S):S139–S144

    Google Scholar 

Download references

Funding

This study was not funded by any entity.

Author information

Authors and Affiliations

  1. Department of Audiology, Faculty of Health Sciences, Hacettepe University, 06100, Ankara, Turkey

    Oznur Yigit

  2. Department of Speech and Language Therapy, Faculty of Health Sciences, Hacettepe University, Ankara, Turkey

    Mavis Emel Kulak Kayikci

  3. Department of Neurology, Faculty of Medicine, Hacettepe University, Ankara, Turkey

    Cagri Mesut Temucin

  4. Department of Ear Nose and Throat, Faculty of Medicine, Koc University, Istanbul, Turkey

    Sarp Sarac

  5. Department of Medical Oncology, Faculty of Medicine, Hacettepe University, Ankara, Turkey

    Mustafa Erman

  6. Department of Audiology, Faculty of Health Sciences, Medipol University, Istanbul, Turkey

    Erol Belgin

Authors
  1. Oznur Yigit
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Mavis Emel Kulak Kayikci
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Cagri Mesut Temucin
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Sarp Sarac
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Mustafa Erman
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Erol Belgin
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Oznur Yigit.

Ethics declarations

Conflict of Interest

Authors declare that they have no conflict of interest.

Ethical approval

All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards.

Informed consent

Informed consent was obtained from all individual participants included in the study.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Yigit, O., Kulak Kayikci, M.E., Temucin, C.M. et al. Electrophysiologic evaluation of facial nerve functions after oxaliplatin treatment. Cancer Chemother Pharmacol 84, 513–520 (2019). https://doi.org/10.1007/s00280-019-03841-2

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00280-019-03841-2

Keywords

Search

Navigation